The increasing number of surgical procedures worldwide, the rising prevalence of chronic diseases along with a significant rise in the geriatric population and the availability of specialized retraction products are some of the key factors driving the market for surgical retractors.
The global Surgical Retractors Market is
projected to reach USD 2.8 billion by 2027 from USD 1.9 billion in 2022, at a
CAGR of 6.7%.
Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121697708
Growth Driver: Increasing number of surgical
procedures worldwide
Surgical retractors are widely used in open surgeries, endoscopy,
dermatology, ophthalmology, and dentistry. Over the years, the affordability
and accessibility of surgical care have increased, leading to a significant
rise in the number of surgical procedures performed utilizing surgical
retractors. The increasing prevalence of chronic diseases and a subsequent rise
in surgical procedures have increased the demand for advanced surgical
equipment, including surgical retractors.
Opportunity: High growth opportunities in emerging
markets
Emerging countries (such as China, Brazil, Mexico, and India)
present significant growth opportunities for players in the market. The demand
for surgical retractor devices in these countries is increasing owing to the
rapid growth in healthcare infrastructure, increasing public and private
healthcare expenditure, and growth in medical tourism. Additionally, the rising
number of well-skilled surgeons, coupled with a sharp rise in target surgical
procedures across these countries, is also poised to contribute to overall
demand growth. Other emerging countries are also witnessing rapid modernization
of their healthcare facilities and the expansion of healthcare infrastructure.
This factor is contributing to the increased procurement of medical devices and
surgical instruments.
Market Segmentation:
The handheld retractors segment accounted for the
largest share of the surgical retractors market, by product in 2021.
Based on product, the global surgical retractors market is
segmented into handheld retractors, self-retaining retractors, table-mounted
retractors, wire retractors, and retractor accessories. In 2021, the handheld
retractors segment accounted for the largest share of this market. This is
mainly due to the growing number of surgical procedures globally and the
availability of affordable hand-operated surgical retractors.
The tissue handling and dissection segment is
expected to register the highest CAGR during the forecast period
Based on usage, the surgical retractors market is segmented into
tissue handling and dissection, and fluid swabbing. The highest growth of the
tissue handling and dissection segment can be attributed to the increased
handling of tissues, organs, and ligaments around the surgical area with the
increasing number of surgical procedures globally.
The head, neck, and spinal surgeries segment is
expected to register the highest CAGR in the surgical retractors application
market during the forecast period
Based on application, the surgical retractors market is
segmented into abdominal surgeries, cardiothoracic surgeries, orthopedic
surgeries, obstetric and gynecological surgeries, urological surgeries,
aesthetic surgeries, head, neck, and spinal surgeries, and other surgeries. The
head, neck, and spinal segment is expected to witness the highest growth during
the forecast period. This can be attributed to the increasing incidence of
spinal disorders across the globe, which in turn has resulted in the growing
volume of surgical procedures performed.
The ambulatory care centers segment to witness the
highest growth during the forecast period
Based on end users, the surgical retractors market is segmented
into hospitals, clinics, and surgical centers, ambulatory care centers, and
maternity and fertility centers. The ambulatory care centers segment is
expected to register the highest growth during the forecast period due to the
increased adoption of getting treated in ambulatory care settings due to the
cost-effective treatment offered.
Regional Analysis:
The Asia Pacific region is expected to witness the
highest growth during the forecast period.
Asia Pacific is expected to witness the highest growth during
the forecast period due to presence of high-growth markets such as India,
China, and Japan, the implementation of favorable government initiatives, and
rapid growth in the geriatric population, are some of the major factors that
are expected to drive the growth of the surgical retractors market in the Asia
Pacific region.
Recent Developments of Surgical Retractors Industry:
- In 2022, Henry Schein acquired acquire
Condor to expand its dental distribution business in Switzerland.
- In 2020, Henry Schein entered into an
agreement with the Dentists Supply Company and this was aimed to form a
new entity - TDSC.com, an online-only option for purchasing dental
supplies that will serve the state dental association members.
- In 2019, Integra LifeSciences acquired
Rebound Therapeutics to develop innovative products to address the unmet
needs in neurosurgery.
- In 2019, Stryker Corporation acquired
Mobius Imaging and Cardan Robotics to expand its presence in the
orthopedics, spine, and neurotechnology divisions using advanced imaging
and robotics as well as a wide product pipeline.
Top Key Players:
The prominent players in the surgical retractors market are
Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Integra
LifeSciences (US), Teleflex Incorporated (US), Medtronic plc (US), Johnson
& Johnson (US), Stryker Corporation (US), Henry Schein, Inc. (US), Sklar
Surgical Instruments (US), Mediflex Surgical Products (US), Medline Industries,
Inc. (US), Bausch Health Companies, Inc. (Canada), Thompson Surgical
Instruments (US), BR Surgical, LLC (US), The Cooper Companies, Inc. (US), Innomed,
Inc. (US), Terumo Corporation (Japan), Globus Medical, Inc. (US), Halma plc
(UK), Enovis Corporation (US), CONMED Corporation (US), Olympus Corporation
(Japan), Arthrex, Inc. (US), Applied Medical Resources Corporation (US), and
LiNA Medical ApS (Denmark).
No comments:
Post a Comment